查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1887135

分子影像市場規模、佔有率、成長及全球產業分析：依類型、應用和地區劃分的洞察與預測（2024-2032 年）

Molecular Imaging Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 180 Pages | 商品交期: 請詢問到貨日

價格

分子影像市場成長推動因素

隨著醫療保健系統擴大採用精準診斷技術來改善疾病檢測和治療監測，全球分子影像市場持續發展。根據最新的行業評估，該市場在 2024 年的價值為 21.9 億美元，到 2025 年增長至 23.2 億美元，預計到 2032 年將達到 34.6 億美元。這一成長的推動因素包括慢性病盛行率的上升、PET 和 SPECT 影像技術的創新，以及已開發市場和新興市場醫療保健基礎設施的不斷改進。

市場趨勢與主要成長推動因素

分子影像透過在細胞和分子層面上可視化生物過程，在複雜疾病的診斷中發揮關鍵作用。對先進影像系統的需求持續成長，主要原因是癌症、神經系統疾病和心血管疾病病例的增加。美國國家癌症研究所（2024 年）預測，2024 年美國將新增 200 萬例癌症病例，凸顯了改善診斷工具的迫切需求。

推動 2024 年和 2025 年市場成長的關鍵因素是老齡人口的快速成長。根據皮尤研究中心 2024 年的報告，美國 65 歲以上老年人口為 6,200 萬，預計到 2054 年將達到 8,400 萬人。老年人口易患阿茲海默症、帕金森氏症和肌肉骨骼疾病，進一步推動了全球對 PET 和 SPECT 掃描儀的需求。

此外，GE醫療、西門子醫療、佳能醫療和飛利浦等主要製造商持續加強研發投入，推出PET/CT和SPECT/CT等先進的混合影像系統。這些技術提高了診斷準確率，並縮短了掃描時間。

市場限制因子

儘管分子影像技術具有顯著優勢，但高昂的投資成本限制了其在中低收入地區的普及。新型PET/CT掃描儀的售價在50萬美元至500萬美元之間，對許多醫療機構構成了經濟障礙。此外，價格低廉得多的翻新設備市場（25萬至45萬美元）正在不斷擴大，對新系統構成了激烈的競爭，尤其是在新興市場。

醫療應用領域的機會

預計到2032年，隨著分子影像技術在心臟病學、腫瘤學、神經病學、骨科、婦科等領域的應用不斷擴展，將迎來顯著的成長機會。即時分子影像技術因其快速出結果和易於操作而日益普及。根據美國國家生物技術資訊中心（NCBI）2021年的一項調查，93%的美國受訪者認為即時檢測（POC​​T）有助於提高醫療保健質量，促使更多醫院和診斷中心投資購買先進的掃描儀。

個人化醫療和精準腫瘤學的進步進一步加速了對分子影像的需求。 PET和SPECT掃描能夠即時評估治療效果，使醫生能夠更有效地制定個人化治療方案。

細分市場分析

依類型

2024年，正子斷層掃描（PET）成為領先細分市場，這主要得益於神經系統疾病和腫瘤病例的增加。根據世界衛生組織（WHO）的報告，加拿大PET掃描儀的普及率很高，每百萬人擁有1.48台PET掃描儀。隨著製造商推出更經濟高效的系統，SPECT技術預計將在2032年之前穩步成長。

依應用

2024年，由於全球癌症負擔日益加重，腫瘤學成為領先領域。美國每年報告的骨科損傷相關住院病例達360萬例，骨科應用也不斷擴展。由於慢性神經系統疾病的增加，預計到 2032 年，神經病學領域將顯著增長。

依最終使用者劃分

由於越來越多的患者尋求更短的等待時間和更先進的影像檢查方案，診斷影像中心預計將成長最快。截至 2023 年，美國將擁有約 19,000 家影像中心，體現了該領域的規模。

區域展望

北美

截至 2024 年，北美地區是最大的市場，其分子影像市值達 9.6 億美元。該地區強勁的醫療保健支出、對先進技術的早期應用以及主要製造商的存在，預計將支撐其在2032年之前繼續保持領先地位。

歐洲

成長的推動力在於PET/CT和SPECT掃描儀的日益普及以及政府對診斷影像研究的支持。荷蘭以每百萬人擁有2.33台PET掃描器位居榜首。

亞太地區

預計該地區將實現最快增長，這得益於不斷增長的醫療保健投資和龐大的老齡人口。到2023年，光是中國就有2.97億60歲以上人口。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場推動因素
  • 市場阻礙因素
  • 市場機遇
  • 市場趨勢

第四章：主要發現

  • 主要國家和地區主要疾病盛行率（2023/2024）
  • 分子影像儀器的技術進步
  • 主要國家和地區的安裝量（2023/2024）
  • 新產品發布狀況主要公司
  • 關鍵產業趨勢：併購與合作
  • 新冠疫情對市場的影響

第五章：全球分子影像市場分析、洞察與預測（2019-2032）

  • 市場分析、洞察與預測 - 依類型劃分
    • 正子斷層掃描 (PET)
    • 單光子發射電腦斷層掃描 (SPECT)
    • 其他
  • 市場分析、洞察與預測 - 依應用劃分
    • 心臟病學
    • 腫瘤學
    • 骨科
    • 婦科
    • 神經病學
    • 其他
  • 市場分析、洞察與預測 - 依最終用途劃分用戶
    • 醫院
    • 專科診所
    • 診斷影像中心
    • 其他
  • 市場分析、洞察與預測 - 依地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第六章：北美分子影像市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 美國
    • 加拿大

第七章：歐洲分子影像市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 美國王國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪的納維亞
    • 歐洲其他地區

第八章 亞太分子影像市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 日本
    • 澳大利亞
    • 中國
    • 印度
    • 東南亞
    • 亞太其他地區

第九章 拉丁美洲分子影像市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區美國

第十章：中東與非洲分子影像市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 海灣合作委員會 (GCC)
    • 南非
    • 中東和非洲其他地區

第十一章 競爭分析

  • 全球市佔率分析（2024）
  • 公司簡介
    • 通用電氣醫療集團 (GE Healthcare)
    • 西門子醫療 (Siemens Healthineers AG)
    • 皇家飛利浦公司 (Koninklijke Philips N.V.)
    • 島津公司 (Shimadzu Corporation)
    • 佳能醫療系統株式會社 (CANON MEDICAL SYSTEMS CORPORATION)
    • 布魯克 (Bruker)
    • 蘭特斯控股公司 (Lantheus Holdings, Inc.)
    • 世上導引株式會社 (Segami Corporation)
Product Code: FBI112879

Growth Factors of molecular imaging Market

The global molecular imaging market continues to advance as healthcare systems increasingly adopt precision diagnostic technologies to improve disease detection and treatment monitoring. According to the latest industry assessments, the market was valued at USD 2.19 billion in 2024 and is projected to grow to USD 2.32 billion in 2025, reaching USD 3.46 billion by 2032. This growth is attributed to rising chronic disease prevalence, technological innovations in PET and SPECT imaging, and expanding healthcare infrastructure in developed and emerging markets.

Market Insights and Key Growth Factors

Molecular imaging plays a crucial role in diagnosing complex diseases by visualizing biological processes at the cellular and molecular levels. Demand for advanced imaging systems continues to rise, primarily due to increasing cases of cancer, neurological disorders, and cardiovascular conditions. The National Cancer Institute (2024) anticipates 2.0 million new cancer cases in the U.S. in 2024, demonstrating the urgent need for improved diagnostic tools.

A significant driver for the market in 2024 and 2025 is the rapid growth of the geriatric population. The Pew Research Center (2024) reported that 62 million adults aged 65+ live in the U.S., expected to reach 84 million by 2054. This aging demographic is more susceptible to Alzheimer's disease, Parkinson's disease, and musculoskeletal conditions-further supporting the need for more PET and SPECT scanners worldwide.

Additionally, leading manufacturers such as GE Healthcare, Siemens Healthineers AG, Canon Medical, and Philips continue to invest in R&D, introducing advanced hybrid imaging systems such as PET/CT and SPECT/CT, which improve diagnostic accuracy and shorten scan times.

Market Restraints

Despite its significant benefits, molecular imaging technology involves high investment costs, limiting adoption in low- and middle-income regions. A new PET/CT scanner costs between USD 0.5 million and USD 5.0 million, creating a financial barrier for many healthcare facilities. Moreover, the growing market for refurbished equipment-priced significantly lower at USD 0.25 million to USD 0.45 million-poses strong competition for new system installations, especially in emerging markets.

Opportunities in Medical Applications

The expanding use of molecular imaging across cardiology, oncology, neurology, orthopedics, and gynecology offers substantial growth opportunities through 2032. Point-of-care molecular imaging is gaining adoption due to faster results and better accessibility. According to a 2021 NCBI survey, 93% of respondents in the U.S. believed POCT improved their care, encouraging more hospitals and diagnostic centers to invest in advanced scanners.

Personalized medicine and precision oncology are further accelerating the demand for molecular imaging. PET and SPECT scans enable real-time evaluation of treatment responses, allowing physicians to tailor therapies more effectively.

Segmentation Analysis

By Type

In 2024, Positron Emission Tomography (PET) was the leading segment, driven by increasing neurological and oncological cases. The WHO reported 1.48 PET scanners per million population in Canada, highlighting strong adoption rates. SPECT technology is expected to grow steadily through 2032 as manufacturers introduce more affordable and efficient systems.

By Application

The oncology segment dominated in 2024 due to an escalating global cancer burden. Orthopedic applications also expanded, supported by 3.6 million orthopedic injury-related hospital visits annually in the U.S. Neurology is anticipated to rise significantly through 2032 as chronic neurological disorders become more common.

By End-User

Diagnostic imaging centers are growing fastest due to greater patient preference for shorter wait times and advanced imaging options. The U.S. had about 19,000 imaging centers in 2023, showcasing the scale of this segment.

Regional Outlook

North America

The largest market in 2024, North America recorded USD 0.96 billion in molecular imaging value. Strong healthcare spending, early adoption of advanced technology, and leading manufacturers in the region support continued dominance through 2032.

Europe

Growth is driven by increasing PET/CT and SPECT installations and government support for imaging research. The Netherlands leads with 2.33 PET scanners per million population.

Asia Pacific

Expected to be the fastest-growing region, supported by rising healthcare investment and a large elderly population. China alone recorded 297 million people aged 60+ in 2023.

Conclusion

With market value rising from USD 2.19 billion in 2024 to USD 2.32 billion in 2025, and projected to reach USD 3.46 billion by 2032, the molecular imaging market is poised for substantial expansion. Advancements in PET and SPECT technology, increasing chronic disease prevalence, and strong demand for precision diagnostics will sustain growth over the forecast period.

a DETAILS

Segmentation By Type

  • Positron Emission Tomography (PET)
  • Single Photon Emission Computed Tomography (SPECT)
  • Others

By Application

  • Cardiology
  • Oncology
  • Orthopedics
  • Gynecology
  • Neurology
  • Others

By End-user

  • Hospitals
  • Specialty Clinics
  • Diagnostic Imaging Centers
  • Others

By Geography

  • North America (By Type, Application, End-user, and Country)
    • U.S.
    • Canada
  • Europe (By Type, Application, End-user, and Country/Sub-region)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Type, Application, End-user, and Country/Sub-region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Type, Application, End-user, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Type, Application, End-user, and Country/Sub-region)
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Key Disorders, Key Countries/Regions, 2023/2024
  • 4.2. Technological Advancements in Molecular Imaging Equipment
  • 4.3. Installed Base, Key Countries/Regions, 2023/2024
  • 4.4. New Product Launches, Key Players
  • 4.5. Key Industry Developments - Mergers, Acquisitions & Partnerships
  • 4.6. Impact of COVID-19 on the Market

5. Global Molecular Imaging Market Analysis, Insights and Forecast, 2019-2032

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Positron Emission Tomography (PET)
    • 5.1.2. Single-Photon Emission Computed Tomography (SPECT)
    • 5.1.3. Others
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Cardiology
    • 5.2.2. Oncology
    • 5.2.3. Orthopedics
    • 5.2.4. Gynecology
    • 5.2.5. Neurology
    • 5.2.6. Others
  • 5.3. Market Analysis, Insights and Forecast - By End User
    • 5.3.1. Hospitals
    • 5.3.2. Specialty Clinics
    • 5.3.3. Diagnostic Imaging Centers
    • 5.3.4. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Molecular Imaging Market Analysis, Insights and Forecast, 2019-2032

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Positron Emission Tomography (PET)
    • 6.1.2. Single-Photon Emission Computed Tomography (SPECT)
    • 6.1.3. Others
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Cardiology
    • 6.2.2. Oncology
    • 6.2.3. Orthopedics
    • 6.2.4. Gynecology
    • 6.2.5. Neurology
    • 6.2.6. Others
  • 6.3. Market Analysis, Insights and Forecast - By End User
    • 6.3.1. Hospitals
    • 6.3.2. Specialty Clinics
    • 6.3.3. Diagnostic Imaging Centers
    • 6.3.4. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Molecular Imaging Market Analysis, Insights and Forecast, 2019-2032

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Positron Emission Tomography (PET)
    • 7.1.2. Single-Photon Emission Computed Tomography (SPECT)
    • 7.1.3. Others
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Cardiology
    • 7.2.2. Oncology
    • 7.2.3. Orthopedics
    • 7.2.4. Gynecology
    • 7.2.5. Neurology
    • 7.2.6. Others
  • 7.3. Market Analysis, Insights and Forecast - By End User
    • 7.3.1. Hospitals
    • 7.3.2. Specialty Clinics
    • 7.3.3. Diagnostic Imaging Centers
    • 7.3.4. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.4.1. U.K.
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Spain
    • 7.4.5. Italy
    • 7.4.6. Scandinavia
    • 7.4.7. Rest of Europe

8. Asia pacific Molecular Imaging Market Analysis, Insights and Forecast, 2019-2032

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Positron Emission Tomography (PET)
    • 8.1.2. Single-Photon Emission Computed Tomography (SPECT)
    • 8.1.3. Others
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Cardiology
    • 8.2.2. Oncology
    • 8.2.3. Orthopedics
    • 8.2.4. Gynecology
    • 8.2.5. Neurology
    • 8.2.6. Others
  • 8.3. Market Analysis, Insights and Forecast - By End User
    • 8.3.1. Hospitals
    • 8.3.2. Specialty Clinics
    • 8.3.3. Diagnostic Imaging Centers
    • 8.3.4. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.4.1. Japan
    • 8.4.2. Australia
    • 8.4.3. China
    • 8.4.4. India
    • 8.4.5. Southeast Asia
    • 8.4.6. Rest of Asia Pacific

9. Latin America Molecular Imaging Market Analysis, Insights and Forecast, 2019-2032

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Positron Emission Tomography (PET)
    • 9.1.2. Single-Photon Emission Computed Tomography (SPECT)
    • 9.1.3. Others
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Cardiology
    • 9.2.2. Oncology
    • 9.2.3. Orthopedics
    • 9.2.4. Gynecology
    • 9.2.5. Neurology
    • 9.2.6. Others
  • 9.3. Market Analysis, Insights and Forecast - By End User
    • 9.3.1. Hospitals
    • 9.3.2. Specialty Clinics
    • 9.3.3. Diagnostic Imaging Centers
    • 9.3.4. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East & Africa Molecular Imaging Market Analysis, Insights and Forecast, 2019-2032

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. Positron Emission Tomography (PET)
    • 10.1.2. Single-Photon Emission Computed Tomography (SPECT)
    • 10.1.3. Others
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Cardiology
    • 10.2.2. Oncology
    • 10.2.3. Orthopedics
    • 10.2.4. Gynecology
    • 10.2.5. Neurology
    • 10.2.6. Others
  • 10.3. Market Analysis, Insights and Forecast - By End User
    • 10.3.1. Hospitals
    • 10.3.2. Specialty Clinics
    • 10.3.3. Diagnostic Imaging Centers
    • 10.3.4. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.4.1. GCC
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2024)
  • 11.2. Company Profiles
    • 11.2.1. GE Healthcare
      • 11.2.1.1. Overview
      • 11.2.1.2. Products
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Siemens Healthineers AG
      • 11.2.2.1. Overview
      • 11.2.2.2. Products
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Koninklijke Philips N.V.
      • 11.2.3.1. Overview
      • 11.2.3.2. Products
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Shimadzu Corporation
      • 11.2.4.1. Overview
      • 11.2.4.2. Products
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. CANON MEDICAL SYSTEMS CORPORATION
      • 11.2.5.1. Overview
      • 11.2.5.2. Products
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Bruker
      • 11.2.6.1. Overview
      • 11.2.6.2. Products
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Lantheus Holdings, Inc.
      • 11.2.7.1. Overview
      • 11.2.7.2. Products
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Segami Corporation
      • 11.2.8.1. Overview
      • 11.2.8.2. Products
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Molecular Imaging Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 2: Global Molecular Imaging Market Revenue (USD billion) Forecast, by Application, 2019-2032
  • Table 3: Global Molecular Imaging Market Revenue (USD billion) Forecast, by End User, 2019-2032
  • Table 4: Global Molecular Imaging Market Revenue (USD billion) Forecast, by Region, 2019-2032
  • Table 5: North America Molecular Imaging Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 6: North America Molecular Imaging Market Revenue (USD billion) Forecast, by Application, 2019-2032
  • Table 7: North America Molecular Imaging Market Revenue (USD billion) Forecast, by End User, 2019-2032
  • Table 8: North America Molecular Imaging Market Revenue (USD billion) Forecast, By Country, 2019-2032
  • Table 9: Europe Molecular Imaging Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 10: Europe Molecular Imaging Market Revenue (USD billion) Forecast, by Application, 2019-2032
  • Table 11: Europe Molecular Imaging Market Revenue (USD billion) Forecast, by End User, 2019-2032
  • Table 12: Europe Molecular Imaging Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 13: Asia Pacific Molecular Imaging Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 14: Asia Pacific Molecular Imaging Market Revenue (USD billion) Forecast, by Application, 2019-2032
  • Table 15: Asia Pacific Molecular Imaging Market Revenue (USD billion) Forecast, by End User, 2019-2032
  • Table 16: Asia Pacific Molecular Imaging Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 17: Latin America Molecular Imaging Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 18: Latin America Molecular Imaging Market Revenue (USD billion) Forecast, by Application, 2019-2032
  • Table 19: Latin America Molecular Imaging Market Revenue (USD billion) Forecast, by End User, 2019-2032
  • Table 20: Latin America Molecular Imaging Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 21: Middle East & Africa Molecular Imaging Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 22: Middle East & Africa Molecular Imaging Market Revenue (USD billion) Forecast, by Application, 2019-2032
  • Table 23: Middle East & Africa Molecular Imaging Market Revenue (USD billion) Forecast, by End User, 2019-2032
  • Table 24: Middle East & Africa Molecular Imaging Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

List of Figures

  • Figure 1: Global Molecular Imaging Market Revenue Breakdown (USD billion, %) by Region, 2024 & 2032
  • Figure 2: Global Molecular Imaging Market Value Share (%), by Type, 2024 & 2032
  • Figure 3: Global Molecular Imaging Market Value Share (%), by Application, 2024 & 2032
  • Figure 4: Global Molecular Imaging Market Value Share (%), by End User, 2024 & 2032
  • Figure 5: Global Molecular Imaging Market Value Share (%), by Region, 2024 & 2032
  • Figure 6: North America Molecular Imaging Market Value (USD billion), by Type, 2024 & 2032
  • Figure 7: North America Molecular Imaging Market Value Share (%), by Type, 2024
  • Figure 8: North America Molecular Imaging Market Value (USD billion), by Application, 2024 & 2032
  • Figure 9: North America Molecular Imaging Market Value Share (%), by Application, 2024
  • Figure 10: North America Molecular Imaging Market Value (USD billion), by End User, 2024 & 2032
  • Figure 11: North America Molecular Imaging Market Value Share (%), by End User, 2024
  • Figure 12: North America Molecular Imaging Market Value (USD billion), By Country, 2024 & 2032
  • Figure 13: North America Molecular Imaging Market Value Share (%), By Country, 2024
  • Figure 14: Europe Molecular Imaging Market Value (USD billion), by Type, 2024 & 2032
  • Figure 15: Europe Molecular Imaging Market Value Share (%), by Type, 2024
  • Figure 16: Europe Molecular Imaging Market Value (USD billion), by Application, 2024 & 2032
  • Figure 17: Europe Molecular Imaging Market Value Share (%), by Application, 2024
  • Figure 18: Europe Molecular Imaging Market Value (USD billion), by End User, 2024 & 2032
  • Figure 19: Europe Molecular Imaging Market Value Share (%), by End User, 2024
  • Figure 20: Europe Molecular Imaging Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 21: Europe Molecular Imaging Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 22: Asia Pacific Molecular Imaging Market Value (USD billion), by Type, 2024 & 2032
  • Figure 23: Asia Pacific Molecular Imaging Market Value Share (%), by Type, 2024
  • Figure 24: Asia Pacific Molecular Imaging Market Value (USD billion), by Application, 2024 & 2032
  • Figure 25: Asia Pacific Molecular Imaging Market Value Share (%), by Application, 2024
  • Figure 26: Asia Pacific Molecular Imaging Market Value (USD billion), by End User, 2024 & 2032
  • Figure 27: Asia Pacific Molecular Imaging Market Value Share (%), by End User, 2024
  • Figure 28: Asia Pacific Molecular Imaging Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 29: Asia Pacific Molecular Imaging Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 30: Latin America Molecular Imaging Market Value (USD billion), by Type, 2024 & 2032
  • Figure 31: Latin America Molecular Imaging Market Value Share (%), by Type, 2024
  • Figure 32: Latin America Molecular Imaging Market Value (USD billion), by Application, 2024 & 2032
  • Figure 33: Latin America Molecular Imaging Market Value Share (%), by Application, 2024
  • Figure 34: Latin America Molecular Imaging Market Value (USD billion), by End User, 2024 & 2032
  • Figure 35: Latin America Molecular Imaging Market Value Share (%), by End User, 2024
  • Figure 36: Latin America Molecular Imaging Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 37: Latin America Molecular Imaging Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 38: Middle East & Africa Molecular Imaging Market Value (USD billion), by Type, 2024 & 2032
  • Figure 39: Middle East & Africa Molecular Imaging Market Value Share (%), by Type, 2024
  • Figure 40: Middle East & Africa Molecular Imaging Market Value (USD billion), by Application, 2024 & 2032
  • Figure 41: Middle East & Africa Molecular Imaging Market Value Share (%), by Application, 2024
  • Figure 42: Middle East & Africa Molecular Imaging Market Value (USD billion), by End User, 2024 & 2032
  • Figure 43: Middle East & Africa Molecular Imaging Market Value Share (%), by End User, 2024
  • Figure 44: Middle East & Africa Molecular Imaging Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 45: Middle East & Africa Molecular Imaging Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 46: Global Molecular Imaging Market Share (%), By Company, 2024